Posted on February 27, 2018 by Sitemaster
Over the past few years, with the increased focus on the idea of “personalized” medicine, we have become increasingly informed about and focused on correlations between genetics and genomics and risk for prostate cancer. However, … READ MORE …
Filed under: Diagnosis, Risk | Tagged: familial, genetic, grandsons, hereditary, risk, sons | 4 Comments »
Posted on January 10, 2018 by Sitemaster
Data from the ongoing, prospective IMPACT study has shown that PSA velocity is not predictive of risk for a positive prostate cancer biopsy result in men who are carriers of the BRCA2 gene. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: BRCA1/2, gene, hereditary, PSA, risk, status, velocity | 1 Comment »
Posted on April 14, 2017 by Sitemaster
Recently posted on the UroToday web site are summaries of four “state-of-the-art” lectures on prostate cancer and its management presented a couple of weeks ago at the annual meeting of the European Association of Urology is London. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: hereditary, mCRPC, mpMRI, review, state-of-the-art | 10 Comments »
Posted on April 11, 2013 by Sitemaster
A new study just published on line in the Journal of Clinical Oncology had confirmed that “BRCA1/2 mutations confer a more aggressive [prostate cancer] phenotype with a higher probability of nodal involvement and distant metastasis.” This is not a surprising finding, but it does have real implications for men with a family history of BRCA1/2 mutations. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: BRCA1, BRCA2, hereditary, mortality, risk, survival | 8 Comments »
Posted on July 21, 2012 by Sitemaster
A new study has confirmed an initial finding that the rare G84E mutation (also known as rs138213197) in the HOXB13 gene is a significant driver of risk for prostate cancer among men with a family history of the disease. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: familial, hereditary, mutation, risk | 1 Comment »
Posted on April 25, 2011 by Sitemaster
For those interested in “brushing up” on their understanding of the risks associated with hereditary and familial forms of prostate cancer, we recommend a brief article in the April issue of the AUA News, which summarizes a “state of the art” lecture to be given by the author at the upcoming annual meeting of the American Urological Association. … READ MORE …
Filed under: Diagnosis, Management, Prevention, Risk | Tagged: familial, genetics, hereditary, heredity, risk | 1 Comment »
Posted on August 17, 2008 by Sitemaster
Additional prostate cancer news this weekend includes the following items:
- The role of follow-up pathology in patients with clinical stage T1a (TURP-detected) prostate cancer
- The impact of the number of risk factors on the likelihood of prostate cancer-specific mortality in patients with intermediate- and high-risk disease
- Whether a familial history of prostate cancer affects outcomes following brachytherapy for localized disease
- Whether obese men are at greater risk for delayed diagnosis of prostate cancer and subsequent poorer outcomes based on current PSA screening recommendations … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: BMI, brachytherapy, cancer, factors, familyt, Gleason, hereditary, history, mortality, news update, obesity, outcome, prostate, prostatectomy, PSA, radical, risk, stage, T1a, TURP, velocity | Leave a comment »